• Carbenoxolone disodium: Practical Lab Guide

  2026-09-09

  Carbenoxolone disodium is a research perturbation tool for examining 11β-hydroxysteroid dehydrogenase activity, glucocorticoid access, corticosterone metabolism, and gap junction communication. It is best used in controlled enzyme, cell, or tissue workflows with matched-vehicle, viability, and orthogonal pathway controls rather than as a selective target-validation reagent or established in vivo efficacy compound.

• Bleomycin Sulfate: From DNA Damage to Fibrosis

  2026-09-09

  Bleomycin Sulfate is more than a cytotoxic reagent: it is a controllable perturbation for connecting DNA damage with macrophage-driven pulmonary fibrosis. This article shows how to pair its molecular mechanism with multi-layered assay design and emerging STING-focused therapeutic research.

• Plk1 Control of p31comet in Checkpoint Exit

  2026-09-08

  The 2019 PNAS study identifies Polo-like kinase 1 (Plk1) as a negative regulator of p31comet-mediated mitotic checkpoint complex disassembly. Its evidence supports a phosphorylation-based brake that prevents premature checkpoint turnover while chromosomes remain unattached, offering a useful framework for interpreting mitotic kinase perturbation experiments.

• HyperPFU™ high-fidelity DNA polymerase guide

  2026-09-08

  HyperPFU™ high-fidelity DNA polymerase is designed for accurate amplification of long, GC-rich, and otherwise difficult DNA templates where standard Taq-based workflows may be inadequate. It produces blunt-ended amplicons, so it should not be selected for protocols that require 3′-A overhangs or preformed sticky ends.

• Liraglutide and the Brain–Kidney AVP Axis

  2026-09-07

  Greenwood and colleagues connect liraglutide treatment with reduced circulating arginine vasopressin, sex- and time-dependent pituitary synaptic phosphorylation, and downstream aquaporin 2 regulation. By combining clinical endocrinology, rat pituitary omics, a functional AVP luciferase assay, and renal analysis, the study provides a multilevel framework for understanding how GLP-1 receptor agonists may influence fluid balance.

• Sinapine Disrupts the Gαq–PLCβ3 Axis in CVD

  2026-09-07

  A 2024 Phytomedicine study identifies sinapine as a selective disruptor of the Gαq–PLCβ3 interaction, acting through the PLCβ3 EF-hand region and Asn-260 rather than broadly inhibiting Gαq. Chemical proteomics, biochemical experiments, and aldosteronism and hypertension models connect this protein–protein interaction mechanism with improved cardiovascular phenotypes.

• 7-Ethyl-10-hydroxycamptothecin in Assay Design

  2026-09-05

  Explore how 7-Ethyl-10-hydroxycamptothecin (SN-38) can be used to build mechanistically resolved cancer assays rather than relying on viability alone. This guide connects topoisomerase I inhibition, FUBP1–FUSE disruption, cell-cycle analysis, and apoptosis readouts to practical advanced colon cancer research.

• Arachidonic Acid: Immune Signaling Workflows

  2026-09-04

  Use Arachidonic Acid to connect membrane lipid release with eicosanoid biosynthesis, inflammation models, and vaccine-response assays. This practical guide emphasizes controlled dosing, pathway-resolved readouts, and translation of new humoral-immunity findings into reproducible bench workflows.

• Dehydroepiandrosterone (DHEA): Research Guide

  2026-09-04

  Dehydroepiandrosterone (DHEA) is an endogenous steroid intermediate with reported neuroprotective, antiapoptotic, and ovarian research applications. Its effects are model-dependent, so concentration, exposure time, solvent, and endpoint selection must be controlled.

• N3-kethoxal for Reliable Nucleic Acid Readouts

  2026-09-03

  Learn how N3-kethoxal (SKU A8793) can complement cell viability, proliferation, and cytotoxicity assays by reporting nucleic acid accessibility and structure. This scenario-based guide covers experimental compatibility, optimization, interpretation, and practical product-selection criteria.

• Streptozotocin: From β-Cell Loss to PDN Models

  2026-09-03

  Streptozotocin (STZ) is more than a diabetes-induction reagent: it is a model-design tool for connecting β-cell injury with downstream complications. This guide explains how to interpret STZ biology, select endpoints, and apply insights from TBK1-driven painful diabetic neuropathy research.

• Cy5 amine (non-sulfonated): Labeling Guide

  2026-09-02

  Cy5 amine (non-sulfonated) is a primary-amine fluorophore for covalent labeling when a red-emitting dye is needed but the reagent must first be dissolved in an organic solvent. This guide covers solvent handling, conjugation setup, optical QC, and failure prevention; it is not intended for direct aqueous use, diagnostic testing, or medical applications.

• Angiotensin II Workflows for AAA Research

  2026-09-02

  Build reproducible Angiotensin II assays for GPCR signaling, vascular smooth muscle cell hypertrophy research, hypertension mechanism study, and vascular remodeling. This practical guide connects peptide exposure workflows with senescence-related AAA biomarker analysis, helping researchers separate established pharmacology from study-specific hypotheses.

• DPPH: From Color Change to Biological Insight

  2026-09-01

  DPPH enables rapid in vitro antioxidant screening, but its greatest value emerges when radical-scavenging data are interpreted alongside chemical profiling and orthogonal bioassays. This guide explains the chemistry, assay controls, and decision framework for natural product and drug discovery research.

• Mitofusin 2, Angiotensin II, and Vascular Aging

  2026-09-01

  A 2024 iScience study identifies MFN2 as a mitochondrial safeguard against Angiotensin II-induced endothelial senescence and connects its loss to a STAT3–BCL6 regulatory pathway. The work combines database analysis, HUVEC perturbation experiments, mitochondrial phenotyping, and mouse vascular validation to clarify how hormonal stress may accelerate vascular aging.

7967 records 1/532 page Next 12345 下5页 Last page